EGFR and K-ras mutations as determinants of gefitinib sensitivity in non-small-cell lung cancer (NSCLC).

被引：0
|
作者：
Han, SW
Jeong, S
Choi, IS
Kim, DN
Chung, DH
Im, SA
Kim, TY
Heo, DS
Bang, YJ
Kim, NK
机构：
[1] Seoul Natl Univ, Coll Med, Seoul, South Korea
[2] ISU ABXIS Inc, Seoul, South Korea
[3] Seoul Municipal Boramae Hosp, Seoul, South Korea
[4] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：639S / 639S
页数：1
相关论文
共 50 条
  • [41] Mutations in the tyrosine kinase domain of the EGFR gene associated with gefitinib response in non-small-cell lung cancer
    Rosell, R
    Ichinose, Y
    Taron, M
    Sarries, C
    Queralt, C
    Mendez, P
    Sanchez, JM
    Nishiyama, K
    Moran, T
    Cirauqui, B
    Mate, JL
    Besse, B
    Reguart, N
    Perez, M
    Sanchez, JJ
    LUNG CANCER, 2005, 50 (01) : 25 - 33
  • [42] EGFR mutations and gefitinib sensitivity in patients with metastatic non-squamous non-small cell lung cancer
    Moiseyenko, V.
    Imyanitov, E.
    Levchenko, E.
    Procenko, S.
    Orlova, R.
    Iyevleva, A.
    Buslov, K.
    Ulibina, Y.
    Matsko, D.
    Moiseyenko, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [43] EGFR MUTATIONS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC) AND CORRELATION WITH SENSITIVITY TO ERLOTINIB
    Ricciardi, S.
    Tedesco, B.
    Migliorino, M. R.
    Graziano, P.
    Leone, A.
    Di Salvia, M.
    Capodaglio, V.
    Condo, S.
    De Santis, S.
    De Marinis, F.
    EJC SUPPLEMENTS, 2008, 6 (14): : 134 - 134
  • [44] Classification of atypical EGFR mutations in non-small-cell lung cancer
    Rosell, R.
    Cardona, A. F.
    Arrieta, O.
    Gonzalez-Cao, M.
    ANNALS OF ONCOLOGY, 2022, 33 (06) : 571 - 573
  • [45] Quantitative analysis of mutated EGFR transcripts for assessment of gefitinib sensitivity of non-small-cell lung cancer.
    Taniguchi, K
    Koizumi, K
    Orita, N
    Sugimoto, Y
    Okami, J
    Higashiyama, M
    Kodama, K
    Kato, K
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9049S - 9049S
  • [46] Intratumor heterogeneity of non-small-cell lung cancer with EGFR mutations
    Qiao, Sitan
    Zhao, Xin
    Zhou, Xinlan
    Zhang, Yaxiong
    Zhang, Li
    Wu, Kui
    CANCER RESEARCH, 2019, 79 (13)
  • [47] Epidermal Growth Factor Receptor and K-Ras mutations in patients with Non Small Cell Lung Cancer
    Mugalaasi, Hood
    Davies, J.
    Medley, L.
    Talbot, D.
    Butler, R.
    Brito, R.
    JOURNAL OF MEDICAL GENETICS, 2009, 46 : S89 - S89
  • [48] MUTATIONAL ACTIVATION OF HUMAN K-RAS ONCOGENE IN NON-SMALL-CELL LUNG CARCINOMAS
    SARKAR, F
    LI, YW
    SAKR, W
    VALDIVIESO, M
    CRISSMAN, J
    LABORATORY INVESTIGATION, 1992, 66 (01) : A116 - A116
  • [49] Prognostic significance of K-ras codon 12 mutations in patients with resected stage I and II non-small-cell lung cancer
    Graziano, SL
    Gamble, GP
    Newman, NB
    Abbott, LZ
    Rooney, M
    Mookherjee, S
    Lamb, ML
    Kohman, LJ
    Poiesz, BJ
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (02) : 668 - 675
  • [50] EGFR mutation conferring primary resistance to gefitinib in non-small-cell lung cancer
    Shih, JY
    Gow, CH
    Yang, PC
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02): : 207 - 208
12345